摘要
甲状腺癌是近10年发病率增长最快的内分泌肿瘤之一,在所有恶性肿瘤中占比约3%[1]。其中,原发性甲状腺鳞状细胞癌(primary squamous cell carcinoma thyroid,PSCCT)临床极少见,占所有甲状腺癌的0.2%~1%[2]。但其恶性程度高、进展快、易转移、预后差,中位生存期仅6个月左右。
作者
刘玉婷
陈婕
饶丹
吕毕
宝荣
方超
谭兴容
Liu Yuting;Chen Jie;Rao Dan;Lü Bi;Bao Rong;Fang Chao;Tan Xingrong(Department of Endocrinology,The Ninth People’s Hospital of Chongqing;Department of General Surgery,Zengjia Hospital of Chongqing High-tech Zone;Department of Ultrasound,The Ninth People’s Hospital of Chongqing;Department of Pathology,The Ninth People’s Hospital of Chongqing)
出处
《重庆医科大学学报》
CAS
CSCD
北大核心
2022年第11期1289-1292,共4页
Journal of Chongqing Medical University
